Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
208.47
USD
+1.55 (+0.75%)
Streaming Delayed Price
Updated: 2:20 PM EST, Mar 8, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Eli Lilly
< Previous
1
2
...
93
94
95
96
97
98
99
100
Next >
Benzinga's Option Alert Recap From May 16
May 16, 2017
Benzinga Pro provides its subscribers with real-time alerts of potentially market-moving options activity. Here's a recap of the ...
Tags
LLY
Movers
options
From
Benzinga
Lilly Could Grab Diabetes Share From Dow's J&J On Amputation Woes
May 16, 2017
Lilly's Jardiance will likely benefit most after regulators required J&J to warn patients of amputations associated with diabetes drug Invokana.
Tags
Technology
From
Investor's Business Daily
Notable Tuesday Option Activity: LLY, HON, XONE
May 16, 2017
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Lilly (Eli) & Co (LLY), where a total volume of 24,278 contracts has been traded...
Tags
Stocks
From
Market News Video
Citi Cuts Pfizer To Sell On Oncology Drug, M&A Risks
May 16, 2017
Shares of Pfizer are falling after Citi analyst Andrew Baum downgraded the stock to Sell from Neutral and lowered his target price to $31 from $38.
Tags
Stocks / Equities
Healthcare
From
Blogs - TalkMarkets
Dow's Pfizer, Eli Lilly Topple To 3-Month Lows On Downgrades
May 16, 2017
Eli Lilly and Pfizer stocks toppled to three-month lows Tuesday after sustaining a pair of downgrades.
Tags
Technology
From
Investor's Business Daily
BRIEF-3Sbio Inc enters distribution and promotion agreement with two subsidiaries of Eli Lilly
May 16, 2017
* Enters distribution and promotion agreement with two subsidiaries of Eli Lilly and co for distribution and promotion of insulin products
Tags
companyNews
From
Reuters: Company News
BRIEF-Lupin and Lilly expand partnership in India
May 15, 2017
* Says Lilly will be responsible for manufacturing and importing the product
Tags
companyNews
From
Reuters: Company News
BRIEF-Soros Fund Management dissolves share stake in Ebay Inc
May 15, 2017
* Soros Fund Management takes share stake of 3,900 shares in Eli Lilly & Co
Tags
companyNews
From
Reuters: Company News
HDV, BA, TXN, LLY: Large Outflows Detected at ETF
May 15, 2017
Symbols mentioned in this story: HDV, BA, TXN, LLY Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''...
Tags
ETFs
From
ETF Channel
Can Teva Hold Its Own In Bringing Migraine Drugs To Market?
May 12, 2017
Teva will square off with Eli Lilly, Amgen, Novartis and Alder next month when it unveils the results of a Phase 3 study in migraines.
Tags
Technology
From
Investor's Business Daily
UPDATE 1-Lilly migraine treatment meets main goal in late-stage studies
May 12, 2017
May 12 (Reuters) - Eli Lilly and Co said on Friday its experimental treatment met the main goal of reducing the number of monthly migraine headache days compared to a placebo in three late-stage...
Tags
companyNews
From
Reuters: Company News
Lilly migraine treatment meets main goal in late-stage studies
May 12, 2017
May 12 (Reuters) - Eli Lilly and Co said on Friday its experimental migraine treatment met the main goal of reducing the number of monthly migraine headache days compared to a placebo in three...
Tags
companyNews
From
Reuters: Company News
BRIEF-Lilly announces positive results for three phase 3 studies of galcanezumab
May 11, 2017
* Lilly announces positive results for three phase 3 studies of galcanezumab for the prevention of episodic and chronic migraine
Tags
companyNews
From
Reuters: Company News
How Secure Is Advantage In Lung Cancer Treatment For Dow's Merck?
May 11, 2017
Merck's Keytruda now has a one- to two-year lead on Bristol, AstraZeneca and Roche in advanced lung cancer.
Tags
Technology
From
Investor's Business Daily
UPDATE 1-U.S. FDA approves Merck immunotherapy/chemo combo for lung cancer
May 10, 2017
May 10 (Reuters) - Merck & Co said on Wednesday U.S. health regulators approved its Keytruda in combination with chemotherapy for previously untreated advanced lung cancer, solidifying the drugmaker's...
Tags
companyNews
From
Reuters: Company News
Eli Lilly raised prices on 9 drugs last week
May 10, 2017
The increases fit a pattern at Lilly and many other drugmakers of single-digit percentage hikes once or twice a year, despite political pressure.
Tags
Health Care
People/Political Leaders/Bernie Sanders
Express Scripts Holding Co
From
CNBC.com News
Biotech Bonanza – Approaching An Inflection Point
May 06, 2017
Biotechs are performing well this year even in an uncertain environment. Policy clarity is important and we may be approaching an inflection point for them to push higher. Investors should maintain...
Tags
Stocks / Equities
Pharma/Biotech
From
Blogs - TalkMarkets
HDV, TXN, LLY, EMR: ETF Outflow Alert
May 05, 2017
Symbols mentioned in this story: HDV, TXN, LLY, EMR Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''...
Tags
ETFs
From
ETF Channel
Drug Stocks Rally On Relief After GOP Health Care Bill Wins In House
May 04, 2017
Drug stocks popped a collective 1.4% midday Thursday after the GOP health care bill to replace and repeal major portions of ObamaCare narrowly passed in the House.
Tags
Technology
From
Investor's Business Daily
3 Biotech Stocks Projected to Grow Their EPS by at Least 415% in 2018
May 04, 2017
Tags
JNJ
LLY
INCY
From
Motley Fool
10 Companies That Have Paid Dividends for More Than 120 Years
May 03, 2017
Tags
SWK
CL
KO
From
Motley Fool
IPO Preview: Biohaven Pharmaceuticals
May 03, 2017
Biohaven Pharmaceuticals expects to raise $112.6 million in its upcoming IPO ($130.1 million if the underwriters exercise their option to purchase additional shares).
Tags
Stocks / Equities
Healthcare
From
Blogs - TalkMarkets
UPDATE 1-Drugmaker Novo Nordisk nudges up full-year profit outlook after Q1 beat
May 02, 2017
* Novo shares rise 6.9 pct (Adds CEO, share price, background)
Tags
companyNews
From
Reuters: Company News
BRIEF-Eli Lilly and Co sets Q2 2017 dividend of $0.52 per share
May 01, 2017
* Sets quarterly dividend of $0.52 per share Source text for Eikon: Further company coverage:
Tags
companyNews
From
Reuters: Company News
BRIEF-Eli Lilly says got civil investigative demand from Washington AG's office about pricing of insulin products
May 01, 2017
* Lilly says got civil investigative demand from washington ag's office about pricing of insulin products, relationships with pharmacy benefit managers
Tags
companyNews
From
Reuters: Company News
Biotechs Cruise On 6-Day Upswing Despite Price Target Cuts For This Duo
May 01, 2017
Biotech stocks cruised on a six-day upswing Monday despite price target cuts for Alkermes and Alder following their recent first-quarter earnings.
Tags
Technology
From
Investor's Business Daily
Week In Review: Cathay Fortune Pays $186 Million For German Diagnostic Company
April 29, 2017
Cathay Fortune International, a Shanghai healthcare private equity firm, will acquire Berlin's Epigenomics AG for $186 million in cash. Cathay will acquire Epigenomics through a subsidiary, Blitz...
Tags
Healthcare
Stocks / Equities
From
Blogs - TalkMarkets
These 7 Drugmakers Relied on Price Hikes for 100% of Their Earnings Growth in 2016
April 28, 2017
Tags
AMGN
BIIB
PFE
From
Motley Fool
CORRECTED-UPDATE 2-Valeant prices psoriasis treatment at $3,500 per month (April 21)
April 27, 2017
April 21 (Reuters) - Canadian drugmaker Valeant Pharmaceuticals International Inc said it had priced its recently approved plaque psoriasis treatment at $3,500 per month, ahead of an expected U.S....
Tags
companyNews
From
Reuters: Company News
Analyst Sees Eli Lilly Fairly Valued At $81 Per Share, Downgrades To Hold
April 27, 2017
Argus analyst Katelyn Bayone believes shares of Eli Lilly and Co (NYSE: LLY) are fairly valued at around $81, which prompted her to ...
Tags
baricitinib
Analyst Color
Jardiance
From
Benzinga
< Previous
1
2
...
93
94
95
96
97
98
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.